The targeting construct inserted tetracycline response element (TRE or tetO) and a loxP site into intron 1 and fused EGFP, FRT-flanked neomycin resistance cassette and an additional loxP site to the ATG translation initiation site in exon 2. Cre-mediated recombination removed EGFP and FRT-flanked neomycin resistance cassette. (J:196015)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count